These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chemokines as natural HIV antagonists. Verani A; Lusso P Curr Mol Med; 2002 Dec; 2(8):691-702. PubMed ID: 12462390 [TBL] [Abstract][Full Text] [Related]
3. Impact of highly active antiretroviral treatment on expression of HIV-1 coreceptors and ligand levels in peripheral blood from HIV-1 infected patients in China. Fang J; Bai S; Wu L; Zhu X; Yao X; Jin C; Wang C J Int Med Res; 2013 Oct; 41(5):1560-9. PubMed ID: 24043708 [TBL] [Abstract][Full Text] [Related]
4. Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals. Maeda Y; Takemura T; Chikata T; Kuwata T; Terasawa H; Fujimoto R; Kuse N; Akahoshi T; Murakoshi H; Tran GV; Zhang Y; Pham CH; Pham AHQ; Monde K; Sawa T; Matsushita S; Nguyen TV; Nguyen KV; Hasebe F; Yamashiro T; Takiguchi M J Virol; 2020 Jun; 94(12):. PubMed ID: 32295903 [TBL] [Abstract][Full Text] [Related]
5. Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease status. Kreisberg JF; Kwa D; Schramm B; Trautner V; Connor R; Schuitemaker H; Mullins JI; van't Wout AB; Goldsmith MA J Virol; 2001 Sep; 75(18):8842-7. PubMed ID: 11507229 [TBL] [Abstract][Full Text] [Related]
6. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors. Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198 [TBL] [Abstract][Full Text] [Related]
7. V3 loop sequence space analysis suggests different evolutionary patterns of CCR5- and CXCR4-tropic HIV. Bozek K; Thielen A; Sierra S; Kaiser R; Lengauer T PLoS One; 2009 Oct; 4(10):e7387. PubMed ID: 19816596 [TBL] [Abstract][Full Text] [Related]
8. The role of viral coreceptors and enhanced macrophage tropism in human immunodeficiency virus type 1 disease progression. Gorry PR; Sterjovski J; Churchill M; Witlox K; Gray L; Cunningham A; Wesselingh S Sex Health; 2004; 1(1):23-34. PubMed ID: 16335478 [TBL] [Abstract][Full Text] [Related]
9. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211. Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065 [TBL] [Abstract][Full Text] [Related]
10. Reconstructing the dynamics of HIV evolution within hosts from serial deep sequence data. Poon AF; Swenson LC; Bunnik EM; Edo-Matas D; Schuitemaker H; van 't Wout AB; Harrigan PR PLoS Comput Biol; 2012; 8(11):e1002753. PubMed ID: 23133358 [TBL] [Abstract][Full Text] [Related]
11. R5X4 HIV-1 coreceptor use in primary target cells: implications for coreceptor entry blocking strategies. Loftin LM; Kienzle M; Yi Y; Collman RG J Transl Med; 2011 Jan; 9 Suppl 1(Suppl 1):S3. PubMed ID: 21284902 [TBL] [Abstract][Full Text] [Related]
12. HIV coreceptor usage and drug treatment. Regoes R; Bonhoeffer S J Theor Biol; 2002 Aug; 217(4):443-57. PubMed ID: 12234752 [TBL] [Abstract][Full Text] [Related]
13. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection. Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658 [TBL] [Abstract][Full Text] [Related]
14. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis. Yao Q; Compans RW; Chen C Virology; 2001 Jun; 285(1):128-37. PubMed ID: 11414813 [TBL] [Abstract][Full Text] [Related]
15. Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1. van Rij RP; Blaak H; Visser JA; Brouwer M; Rientsma R; Broersen S; de Roda Husman AM; Schuitemaker H J Clin Invest; 2000 Oct; 106(8):1039-52. PubMed ID: 11032864 [TBL] [Abstract][Full Text] [Related]
16. Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro. Saha K; Bentsman G; Chess L; Volsky DJ J Virol; 1998 Jan; 72(1):876-81. PubMed ID: 9420304 [TBL] [Abstract][Full Text] [Related]
17. Increased levels of CD4 T-cell activation in individuals with CXCR4 using viruses in primary HIV-1 infection. Hamlyn E; Hickling S; Porter K; Frater J; Phillips R; Robinson M; Mackie NE; Kaye S; McClure M; Fidler S; AIDS; 2012 Apr; 26(7):887-90. PubMed ID: 22313951 [TBL] [Abstract][Full Text] [Related]
18. CXCR4-Using HIV Strains Predominate in Naive and Central Memory CD4 Roche M; Tumpach C; Symons J; Gartner M; Anderson JL; Khoury G; Cashin K; Cameron PU; Churchill MJ; Deeks SG; Gorry PR; Lewin SR J Virol; 2020 Feb; 94(6):. PubMed ID: 31852784 [TBL] [Abstract][Full Text] [Related]
19. Evidence as a HIV-1 self-defense vaccine of cyclic chimeric dodecapeptide warped from undecapeptidyl arch of extracellular loop 2 in both CCR5 and CXCR4. Misumi S; Takamune N; Ido Y; Hayashi S; Endo M; Mukai R; Tachibana K; Umeda M; Shoji S Biochem Biophys Res Commun; 2001 Aug; 285(5):1309-16. PubMed ID: 11478800 [TBL] [Abstract][Full Text] [Related]